Skip to main content
Log in

The importance of physical function in patients with multiple myeloma for improving quality of life

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

To investigate the relationship between physical function and quality of life in multiple myeloma patients.

Methods

In this retrospective cross-sectional study, data from patients with multiple myeloma (N = 63), who were referred to the department of Rehabilitation Medicine from October 2017 to May 2018, were reviewed. Patients were excluded based on the following criteria: acute illness, unstable medical conditions, impaired cognition or communication, refusal, or inability to perform the assessment. Physical function was evaluated with the Mini-Balance Evaluation Systems Test (Mini-BESTest), and the European Organization for Research and Treatment of Cancer questionnaires QLQ-C30 and QLQ-MY20 were used for the evaluation of quality of life. To evaluate fatigue and psychotic status, the Fatigue Severity Scale and Beck Depression Inventory were used. Patients were divided into two groups (“good-function group” and “poor-function group”), based on previously studied normative values of the Mini-BESTest. Clinical data was reviewed to interrogate the contributing factors of physical function.

Results

Positive correlations were observed between Mini-BESTest scores and all domains of the QLQ-C30. The Mini-BESTest score was lower in patients with lower serum hemoglobin (r = 0.396, p = 0.001) and albumin levels (r = 0.440, p < 0.001), severe disease-related symptoms (r = − 0.39, p = 0.02), and depression (r = − 0.538, p < 0.001). Further, the poor-function group showed lower hemoglobin (p = 0.024) and albumin levels (p = 0.004).

Conclusion

In patients with multiple myeloma, physical function had a significant relationship with quality of life. Low hemoglobin and albumin levels, severe disease- or treatment-related symptoms, and depression were related to decreased physical function, and thus consequentially exert an effect on quality of life in multiple myeloma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sherman A, Simonton S, Latif U, Spohn R, Tricot G (2004) Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant 33(9):955–962

    Article  CAS  Google Scholar 

  2. Poulos AR, Gertz MA, Pankratz S, Post-White J (2001) Pain, mood disturbance, and quality of life in patients with multiple myeloma. Oncol Nurs Forum 28(7):1163–1171

    CAS  PubMed  Google Scholar 

  3. Robinson D Jr, Esseltine DL, Regnault A, Meunier J, Liu K, van de Velde H (2016) The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials. Br J Haematol 174(3):368–381

    Article  CAS  Google Scholar 

  4. Vogl DT, Delforge M, Song K, Guo S, Gibson CJ, Ervin-Haynes A, Facon T (2018) Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone. Leuk Lymphoma 59(2):398–405

    Article  CAS  Google Scholar 

  5. Coleman EA, Goodwin JA, Coon SK, Richards K, Enderlin C, Kennedy R, Stewart CB, McNatt P, Lockhart K, Anaissie EJ, Barlogie B (2011) Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nurs 34(3):219–227

    Article  Google Scholar 

  6. Dimeo F, Schmittel A, Fietz T, Schwartz S, Kohler P, Boning D, Thiel E (2004) Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 15(8):1237–1242

    Article  CAS  Google Scholar 

  7. Franchignoni F, Horak F, Godi M, Nardone A, Giordano A (2010) Using psychometric techniques to improve the balance evaluation systems test: the mini-BESTest. J Rehabil Med 42(4):323–331

    Article  Google Scholar 

  8. Rome SI, Jenkins BS, Lilleby KE (2011) Mobility and safety in the multiple myeloma survivor: survivorship care plan of the International Myeloma Foundation nurse leadership board. Clin J Oncol Nurs 15(4):41–52

    Article  Google Scholar 

  9. Delforge M, Bladé J, Dimopoulos MA, Facon T, Kropff M, Ludwig H, Palumbo A, Van Damme P, San-Miguel JF, Sonneveld P (2010) Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol 11(11):1086–1095

    Article  CAS  Google Scholar 

  10. O’Hoski S, Winship B, Herridge L, Agha T, Brooks D, Beauchamp MK, Sibley KM (2014) Increasing the clinical utility of the BESTest, mini-BESTest, and brief-BESTest: normative values in Canadian adults who are healthy and aged 50 years or older. Phys Ther 94(3):334–342

    Article  Google Scholar 

  11. Yun YH, Park YS, Lee ES, Bang S-M, Heo DS, Park S, You C, West K (2004) Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 13(4):863–868

    Article  CAS  Google Scholar 

  12. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A (2007) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer 43(11):1670–1678

    Article  CAS  Google Scholar 

  13. Fayers P, Bottomley A, Group EQoL (2002) Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 38:125–133

    Article  Google Scholar 

  14. Stone P, Richards M, A’hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11(5):561–567

    Article  CAS  Google Scholar 

  15. Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L (2007) Beck depression inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care 16(3):244–250

    Article  CAS  Google Scholar 

  16. Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5(3):224–237

    Article  CAS  Google Scholar 

  17. Black SA, Rush RD (2002) Cognitive and functional decline in adults aged 75 and older. J Am Geriatr Soc 50(12):1978–1986

    Article  Google Scholar 

  18. Jørgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7):1353–1360

    Article  Google Scholar 

  19. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78(1):21–33

    Article  Google Scholar 

  20. Mittelman M (2003) The implications of anemia in multiple myeloma. Clin Lymphoma 4(Suppl 1):S23–S29

    Article  Google Scholar 

  21. Bladé J, Rosiñol L (2005) Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol 18(4):635–652

    Article  Google Scholar 

  22. Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncol Suppl 2:9–12

    Google Scholar 

  23. Birgegård G, Gascón P, Ludwig H (2006) Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY. Eur J Haematol 77(5):378–386

    Article  Google Scholar 

  24. Kim JE, Yoo C, Lee DH, Kim SW, Lee JS, Suh C (2010) Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma. Ann Hematol 89(4):391–397

    Article  CAS  Google Scholar 

  25. Greipp PR, Miguel JS, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412–3420

    Article  Google Scholar 

  26. Sullivan DH (2001) Guest editorial: what do the serum proteins tell us about our elderly patients? J Gerontol A Biol Sci Med Sci 56(2):M71–M74

    Article  CAS  Google Scholar 

  27. Rummans TA, Frost M, Suman VJ, Taylor M, Novotny P, Gendron T, Johnson R, Hartmann L, Dose AM, Evans RW (1998) Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics 39(5):437–445

    Article  CAS  Google Scholar 

  28. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manag 13(2):63–74

    Article  CAS  Google Scholar 

  29. Paice JA (2004) Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr 32:98–102

    Article  Google Scholar 

  30. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, Kennedy MJ (1999) Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 7(5):240–247

    Article  CAS  Google Scholar 

  31. Alacacioglu A, Binicier O, Gungor O, Oztop I, Dirioz M, Yilmaz U (2010) Quality of life, anxiety, and depression in Turkish colorectal cancer patients. Support Care Cancer 18(4):417–421

    Article  Google Scholar 

  32. Mohan A, Singh P, Singh S, Goyal A, Pathak A, Mohan C, Guleria R (2007) Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status. Eur J Cancer Care (Engl) 16(3):268–276

    Article  CAS  Google Scholar 

  33. O'Brien BJ, Buxton MJ, Patterson DL (1993) Relationship between functional status and health-related quality-of-life after myocardial infarction. Med Care 31(10):950–955

    Article  CAS  Google Scholar 

  34. Young-McCaughan S, Arzola SM (2007) Exercise intervention research for patients with cancer on treatment. Semin Oncol Nurs 23(4):264–274

    Article  Google Scholar 

  35. Headley JA, Ownby KK, John LD (2004) The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum 31(5):977–983

    Article  Google Scholar 

  36. Anderson KC, Kyle RA, Dalton WS, Landowski T, Shain K, Jove R, Hazlehurst L, Berenson J (2000) Multiple myeloma: new insights and therapeutic approaches. Hematol Am Soc Hematol Educ Program 2000(1):147–165

    Article  Google Scholar 

  37. Rajkumar SV (2016) Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91(7):719–734

    Article  CAS  Google Scholar 

  38. Groeneveldt L, Mein G, Garrod R, Jewell AP, Van Someren K, Stephens R, D’Sa SP, Yong KL (2013) A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer 13. https://doi.org/10.1186/1471-2407-13-31

  39. de Morton NA, Davidson M, Keating JL (2010) Validity, responsiveness and the minimal clinically important difference for the de Morton Mobility Index (DEMMI) in an older acute medical population. BMC Geriatr 10. https://doi.org/10.1186/1471-2318-10-72

  40. MacKnight C, Rockwood K (2000) Rasch analysis of the hierarchical assessment of balance and mobility (HABAM). J Clin Epidemiol 53(12):1242–1247

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1A2B6001296).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kwan Sik Seo.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.H., Kim, I., Koh, Y. et al. The importance of physical function in patients with multiple myeloma for improving quality of life. Support Care Cancer 28, 2361–2367 (2020). https://doi.org/10.1007/s00520-019-05054-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-05054-y

Keywords

Navigation